MNOV — Medicinova Cashflow Statement
0.000.00%
Last trade - 00:00- $59.84m
- $15.50m
- $1.00m
- 55
- 23
- 42
- 34
Annual cashflow statement for Medicinova, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.9 | -13.9 | -10.1 | -14.1 | -8.57 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 4.11 | 3.18 | 1.93 | 0.806 | 1.01 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.32 | -0.169 | -1.21 | 0.334 | 0.112 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -9.12 | -10.8 | -9.38 | -12.9 | -7.43 |
| Capital Expenditures | -0.011 | -0.036 | -0.029 | -0.005 | -0.021 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | -40 | 39.9 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.011 | -0.036 | -0.029 | -40 | 39.9 |
| Financing Cash Flow Items | — | -0.204 | -0.118 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 10.6 | 7.11 | 20.8 | 0.008 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.48 | -3.76 | 11.4 | -52.9 | 32.5 |